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Arsenic Makes Its Mark
Using Biomarkers to Track Noncancer
Respiratory Effects
Exposure to toxic levels of arsenic is a serious problem in many
Asian countries, notably Bangladesh and India, where exposure to
inorganic arsenic through naturally contaminated groundwater is
widespread and often excessive. Scientists have long recognized the
lung to be a major site of action of ingested arsenic, and most of the
focus has been on risks associated with lung cancer. Nonetheless,
habitual ingestion of high-arsenic drinking
water also promotes many noncancer lung
effects, and researchers are investigating
the potential utility of biomarkers to
identify such effects [EHP 116:190–195;
Parvez et al.].
One of the challenges of pursuing con-
nections between arsenic and respiratory
illness is that assessments of respiratory
symptoms may be prejudiced by inter-
viewer bias if study participants show visi-
ble skin lesions, a hallmark sign of chronic
arsenic poisoning. To overcome this
obstacle, researchers have begun exploring
the use of biomarkers for chronic respira-
tory disease such as serum levels of Clara
cell protein CC16. This serum marker
runs low in individuals with compromised
lung conditions induced by chronic envi-
ronmental exposures such as cigarette
smoking or ozone.
In the current study, investigators
sought to determine the relationships of
serum CC16 with well-water arsenic,
total urinary arsenic, and urinary arsenic
methylation indices in a population of
241 nonsmoking individuals exposed to
arsenic-laden drinking water in Araihazar,
Bangladesh. The mean arsenic concentration in drinking water
was 134 µg/L, and individuals with skin lesions consumed signif-
icantly more arsenic than those without (159 versus 105 µg/L,
respectively). 
In individuals with skin lesions (but not those without such
lesions), there was a significant inverse association of CC16 with
urinary arsenic as well as a marginally significant inverse associa-
tion of CC16 with the cumulative arsenic exposure index, which
estimates long-term exposure. The researchers speculate that indi-
viduals with skin lesions either are exposed to higher levels of
arsenic or have a unique susceptibility to the respiratory effects of
arsenic exposure for reasons unknown.
The analysis also revealed positive asso-
ciations of CC16 levels with the secondary
arsenic methylation index (an indicator of
arsenic methylation capability), particular-
ly among individuals without skin lesions.
This suggests that individuals with better
methylation capacity may be less suscepti-
ble to the adverse respiratory effects of
arsenic. Moreover, the inverse association
of CC16 with the percentage of mono-
methylated arsenic (a commonly measured
arsenic metabolite) in urine indicates that
individuals with incomplete methylation
may be more vulnerable to arsenic-induced
respiratory problems.
This cross-sectional investigation, the
first to use biomarkers of arsenic exposure
and lung injury in this way, is an impor-
tant step toward further improving our
understanding of arsenic-related non-
malignant respiratory illness. Serum CC16
shows promise as a biomarker for assessing
early respiratory damage induced by
arsenic, especially among individuals with
skin lesions associated with the consump-
tion of arsenic-contaminated drinking
water. –M. Nathaniel Mead
Testing Lead’s Limits
Time for Another Reassessment of Guidelines?
Cohort data during the 1980s linked blood lead levels of at least
10 µg/dL with low cognitive test scores in children, prompting the
decision by the Centers for Disease Control and Prevention to re-
define the action level for elevated blood lead from 25 to 10 µg/dL.
Now, new data add to the growing evidence that the 10-µg/dL level
may not be protective [EHP 116:243–248; Jusko et al.].
The investigators recruited children aged 24–30 months who
had been previously enrolled in a dust control study. All the chil-
dren were born between July 1994 and January 1995 and lived in
Rochester, New York, with parents expressing no plans to relo-
cate. To reduce the possibility of misclassification of exposure,
blood samples were collected for measuring blood lead on up to 8
occasions (at ages 6, 12, and 18 months, and annually from age 2
through 6 years). 
The children were given the Wechsler Preschool and Primary
Scale of Intelligence during their 6-year visit by an examiner trained
in neurobehavioral testing and blinded to each child’s blood lead
level. These assessments were made at an age when IQ is measured
reliably and is a significant predictor of IQ scores and educational
and occupational success during adolescence and adulthood. The
data analysis employed a regression model that controlled for family
income; maternal education, race, prenatal smoking, and Stanford-
Binet IQ score; child’s birth weight; breastfeeding; crowding in the
home; and quality of childrearing (using the Home Observation for
Measurement of the Environment Inventory). 
The average blood lead level was 7.2 µg/dL, and lead concen-
trations for more than half the children never exceeded the
10 µg/dL mark. Even at these concentrations, blood lead levels
were inversely related to IQ scores. The association was most pro-
nounced for the Full-Scale and Performance IQ scores. Children
whose blood lead levels measured in the 5- to 9.9-µg/dL range had
significantly lower IQ scores than children with levels below
5 µg/dL. A descriptive analysis of peak exposure throughout early
childhood suggested an inverse association between maximal blood
lead level and IQ at blood lead levels less than 3 µg/dL; levels as
low as about 2 µg/dL were associated with significant IQ declines.
These findings, reinforced by previous data gathered by the same
research team, support the need for a further reassessment of stan-
dard guidelines for responding to blood lead in infants and
children. –M. Nathaniel Mead
As it happens . . . Lung cancer isn’t the only respira-
tory effect linked with drinking arsenic-contaminated
water; noncancer effects also may occur.Science Selections
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Exposure Under Pressure
Lead Linked to Release of Cortisol in Children
Lead exposure is linked to cognitive deficits, cardiovascular disease
risk, and behavioral problems, outcomes that potentially follow
dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis. In
animal studies, lead exposure has heightened the release of cortico-
sterone, the counterpart to the human stress hormone cortisol. New
research now reveals for the first time a similar response in children
with blood lead levels below 10 µg/dL, the action level established
by the Centers for Disease Control and Prevention [EHP
116:249–255; Gump et al.]. This finding corroborates concerns that
there is no safe level of lead exposure.
The researchers drew their study population from the ongoing
Oswego Children’s Study, a longitudinal study at the State University
of New York at Oswego’s Center for Neurobehavioral Effects of
Environmental Toxics. Of the 169 children in the current study,
blood lead levels were known for 154 prenatally (≤1–6.3 µg/dL) and
for 120 during infancy or toddlerhood (1.5–13.1 µg/dL). At the time
of their participation in the current study, children were 9.5 years old.
Cortisol levels vary diurnally, rising quickly after awakening and
then declining steadily thereafter. To help control for this diurnal
variation, tests always occurred in the late afternoon. Beginning with
a brief rest period, each child’s session involved submerging an arm in
ice water for 1 minute and completing a series of simple tasks with
intervening rest periods—a standard protocol to assess neuro-
endocrine response to acute stress. Saliva was collected for cortisol
measurements during the first rest period and at 21, 40, and 60 min-
utes after the cold stressor test.
The researchers controlled for numerous potentially confound-
ing factors, including demographics, socioeconomic status, and the
health, nutrition, and substance use of mothers and children. They
also tested for the presence of other neurotoxicants such as poly-
chlorinated biphenyls, DDE, and hexachlorobenzene in children’s
blood, as well as maternal mercury exposure. 
Pre- and postnatal blood lead were not associated with any vari-
ation in baseline cortisol levels. However, increasing blood lead lev-
els were independently and significantly associated with increasing
cortisol responses to stress. Curiously, cortisol levels remained ele-
vated throughout the test period instead of tapering off as expect-
ed. The authors suggest that the children may have already been
stressed when the test began or that 60 minutes was insufficient for
cortisol levels to return to baseline. 
The precise mechanisms of lead’s effect on the HPA axis are
unclear. However, given the effects they found at relatively low
lead exposures, the authors suggest that cortisol reactivity be con-
sidered in future studies as a potential mediator of lead-induced
disorders. –Julia R. Barrett
Revisiting the DDE–Lactation
Question 
Association Not Confirmed in Breastfeeding
Mothers
Breastfeeding is known to be protective of newborn health, for
example by lowering infant mortality and
risk of infectious diseases. But breastfeeding
is on the decline in some locales, especially
in developing countries. Some studies have
reported a link between elevated maternal
serum DDE (the primary metabolite of the
pesticide DDT) and shorter breastfeeding
duration, suggesting that exposure to DDT
affects the ability to breastfeed. New
research does not confirm this hypothesis,
however, and suggests possible ways to
refine our understanding of the association
previously reported with DDE [EHP
116:179–183; Cupul-Uicab et al.].
Both DDT and DDE are retained in
fatty tissue and excreted in breast milk. DDT
was banned in the United States in 1972 but
is still being used elsewhere to fight malaria.
Given DDT’s prominence in malaria pre-
vention, it is important to determine
whether it affects infant and maternal health.
The current study involved 784 mother–
son pairs from Tapachula, Chiapas, Mexico,
where DDT had been used for about 40
years. The pairs had previously participated
in a study of DDE’s antiandrogenic effects,
in which the mothers’ serum levels of DDT
and DDE were measured shortly after deliv-
ery. For the current study, the researchers
interviewed each mother about every 2 months until her baby was
weaned to determine the length of lactation.
The Tapachula women’s serum levels of DDE were about 15
times higher than recently measured levels in U.S. women. The team
was not surprised to find higher DDE levels in first-time breastfeed-
ers, because experienced breastfeeders would already have transferred
some of their DDE body burden to earlier children. In the group as a
whole, few women reported problems starting breastfeeding, and the
median nursing duration was 10.8 months. 
The researchers found a statistically sig-
nificant positive association between DDE
and shorter duration of lactation, but only
among women who had previously breast-
fed. This is consistent with some earlier
research. But the team writes that it is
probably an artifact rather than a causal
link; otherwise, an association between
DDE and shortened lactation would have
been observed in both experienced and
novice breastfeeders. Only 11 women could
not breastfeed—too small a number for sta-
tistical significance—but these women did
have higher median serum DDE concen-
trations than the other women in the study.
Although the authors found no link
between DDE and shortened breastfeeding
duration, they write that DDT exposure
may make it more difficult to initiate
breastfeeding, perhaps because of endocrine
disruption early in lactation. For the first
2–3 days, lactation is controlled by hor-
mones. If DDE behaves like estrogen, it
could suppress initial milk production but
have a weaker effect on established lacta-
tion. Future research could focus on this
avenue by which DDE may affect successful
breastfeeding. –Valerie J. Brown
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Good news for now. Data from a study of Mexican
mothers do not support earlier concerns that DDT
exposure might impede lactation.